| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Institute of Human Genetics [R. V., A. R., K. Sp.] and Department of Pediatric Oncology/Hematology [G. H., H. G. v. E., K. Se.], Charité, Humboldt-University, 13353 Berlin, Germany, and Molecular Genetics and Gene Mapping Centre, Max-Delbrueck-Centre, 13092 Berlin, Germany [A. R.]
The Nijmegen Breakage Syndrome (NBS) is a rare autosomal recessive disorder associated with immune deficiency, chromosome fragility, and increased susceptibility to lymphoid malignancies. The aim of the present study was to elucidate the potential role of the gene mutated in NBS (NBS1) in the pathogenesis and disease progression of childhood acute lymphoblastic leukemia (ALL). Samples from 47 children with first relapse of ALL were analyzed for mutations in all 16 exons of the NBS1 gene, and in 7 of them (14.9%), four novel amino acid substitutions were identified. Mutations S93L, D95N, and I171V occur in the two known domains of nibrin that are probably involved in protein-protein interactions. Germ-line origin of the I171V mutation was confirmed in three patients, whereas the D95N exchange was present only in leukemic cells. The R215W mutation was observed in one ALL but also in a population-based study and probably represents a rare sequence variant. No additional mutations were found on the second allele in any of these seven patients. The observed NBS1 gene mutations in ALL patients points to its possible involvement in the pathogenesis of this disease.
This article has been cited by other articles:
![]() |
T. J. Gaymes, S. Shall, L. J. MacPherson, N. A. Twine, N. C. Lea, F. Farzaneh, and G. J. Mufti Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes Haematologica, May 1, 2009; 94(5): 638 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gaymes, S. Shall, F. Farzaneh, and G. J. Mufti Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors Haematologica, December 1, 2008; 93(12): 1886 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, M. A. Grotzer, T. Watanabe, E. Hewer, T. Pietsch, S. Rutkowski, and H. Ohgaki Mutations in the Nijmegen Breakage Syndrome Gene in Medulloblastomas Clin. Cancer Res., July 1, 2008; 14(13): 4053 - 4058. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Seemanova, P. Jarolim, P. Seeman, R. Varon, M. Digweed, M. Swift, and K. Sperling Cancer Risk of Heterozygotes With the NBN Founder Mutation J Natl Cancer Inst, December 19, 2007; 99(24): 1875 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kruger, I. Demuth, H. Neitzel, R. Varon, K. Sperling, K. H. Chrzanowska, E. Seemanova, and M. Digweed Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein Carcinogenesis, January 1, 2007; 28(1): 107 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Heikkinen, K. Rapakko, S.-M. Karppinen, H. Erkko, S. Knuutila, T. Lundan, A. Mannermaa, A.-L. Borresen-Dale, A. Borg, R. B. Barkardottir, et al. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability Carcinogenesis, August 1, 2006; 27(8): 1593 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Seemanova, K Sperling, H Neitzel, R Varon, J Hadac, O Butova, E Schrock, P Seeman, and M Digweed Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability J. Med. Genet., March 1, 2006; 43(3): 218 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Yang, W.-C. Chiang, T.-Y. Chou, S.-Y. Chang, P.-M. Chen, S.-C. Teng, and K.-J. Wu Increased NBS1 Expression Is a Marker of Aggressive Head and Neck Cancer and Overexpression of NBS1 Contributes to Transformation Clin. Cancer Res., January 15, 2006; 12(2): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Chen, Y.-N. Su, P.-C. Chou, W.-C. Chiang, M.-C. Chang, L.-S. Wang, S.-C. Teng, and K.-J. Wu Overexpression of NBS1 Contributes to Transformation through the Activation of Phosphatidylinositol 3-Kinase/Akt J. Biol. Chem., September 16, 2005; 280(37): 32505 - 32511. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cybulski, B. Gorski, T. Debniak, B. Gliniewicz, M. Mierzejewski, B. Masojc, A. Jakubowska, J. Matyjasik, E. Zlowocka, A. Sikorski, et al. NBS1 Is a Prostate Cancer Susceptibility Gene Cancer Res., February 15, 2004; 64(4): 1215 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Heikkinen, S-M Karppinen, Y Soini, M Makinen, and R Winqvist Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility J. Med. Genet., December 1, 2003; 40(12): e131 - 131. [Full Text] |
||||
![]() |
G. M. Taylor, H. P. O'Brien, M. F. Greaves, P. F. Ravetto, and O. B. Eden Correspondence re: R. Varon et al., Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res., 61: 3570-3572, 2001. Cancer Res., October 1, 2003; 63(19): 6563 - 6564. [Full Text] [PDF] |
||||
![]() |
Y.-C. Chiang, S.-C. Teng, Y.-N. Su, F.-J. Hsieh, and K.-J. Wu c-Myc Directly Regulates the Transcription of the NBS1 Gene Involved in DNA Double-strand Break Repair J. Biol. Chem., May 23, 2003; 278(21): 19286 - 19291. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |